{"version":"1.0","type":"link","title":"Population Pharmacokinetics and Exposure-Response Analyses for Telisotuzumab Vedotin in Patients With c-Met Protein Overexpressing Tumors.","author_name":"Babel H 외","author_url":"https://prs-insight.online/author/Babel%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96320","thumbnail_width":1200,"thumbnail_height":630}